Bausch + Lomb Operating Margin 2021-2025 | BLCO
Current and historical operating margin for Bausch + Lomb (BLCO) over the last 10 years. The current operating profit margin for Bausch + Lomb as of June 30, 2025 is 3.11%.
| Bausch + Lomb Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $4.89B | $0.04B | 0.74% |
| 2025-03-31 | $4.83B | $0.07B | 1.51% |
| 2024-12-31 | $4.79B | $0.16B | 3.38% |
| 2024-09-30 | $4.68B | $0.12B | 2.65% |
| 2024-06-30 | $4.50B | $0.12B | 2.69% |
| 2024-03-31 | $4.31B | $0.14B | 3.20% |
| 2023-12-31 | $4.15B | $0.13B | 3.14% |
| 2023-09-30 | $3.97B | $0.13B | 3.33% |
| 2023-06-30 | $3.90B | $0.14B | 3.53% |
| 2023-03-31 | $3.81B | $0.15B | 3.96% |
| 2022-12-31 | $3.77B | $0.21B | 5.49% |
| 2022-09-30 | $3.77B | $0.25B | 6.57% |
| 2022-06-30 | $3.78B | $0.30B | 7.83% |
| 2022-03-31 | $3.77B | $0.30B | 7.90% |
| 2021-12-31 | $3.77B | $0.33B | 8.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.984B | $4.791B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.528B | 27.92 |
| CVS Health (CVS) | United States | $84.635B | 10.52 |
| Elevance Health (ELV) | United States | $66.524B | 8.95 |
| Cencora (COR) | United States | $57.169B | 19.04 |
| DiDi Global (DIDIY) | China | $25.839B | 27.45 |
| Labcorp Holdings (LH) | United States | $22.541B | 17.92 |
| Natera (NTRA) | United States | $21.746B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.467B | 0.00 |
| ICON (ICLR) | Ireland | $14.162B | 13.62 |
| CochLear (CHEOY) | Australia | $12.971B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.885B | 34.10 |
| Solventum (SOLV) | United States | $12.692B | 13.10 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.402B | 0.00 |
| Revvity (RVTY) | United States | $10.383B | 18.29 |
| Sonic Healthcare (SKHHY) | Australia | $9.173B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.668B | 14.55 |
| HealthEquity (HQY) | United States | $7.561B | 33.12 |
| Sotera Health (SHC) | United States | $4.477B | 25.02 |
| BrightSpring Health Services (BTSG) | United States | $4.000B | 30.51 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.530B | 80.84 |
| Concentras Parent (CON) | United States | $2.998B | 19.02 |
| Alignment Healthcare (ALHC) | United States | $2.935B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.885B | 36.29 |
| Organon (OGN) | United States | $2.441B | 2.66 |
| Premier (PINC) | United States | $2.028B | 15.39 |
| Progyny (PGNY) | United States | $1.939B | 41.00 |
| Ardent Health (ARDT) | United States | $1.787B | 6.90 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.353B | 9.03 |
| Teladoc Health (TDOC) | United States | $1.290B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.230B | 20.82 |
| Omada Health (OMDA) | $1.175B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.811B | 4.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.716B | 8.85 |
| CareDx (CDNA) | United States | $0.629B | 11.59 |
| Nutex Health (NUTX) | United States | $0.617B | 9.35 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| So-Young (SY) | China | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.481B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.477B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.468B | 10.53 |
| Agilon Health (AGL) | United States | $0.439B | 0.00 |
| SBC Medicals (SBC) | United States | $0.421B | 9.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.407B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 24.63 |
| Oncology Institute (TOI) | United States | $0.327B | 0.00 |
| LifeMD (LFMD) | United States | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.273B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| KindlyMD (NAKA) | United States | $0.114B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |